Research & Literature

Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.

Kuruvilla S, Janardhanan R, Antkowiak P, et al.

JACC. Cardiovascular imaging 2015; (8(2)):172-80.

[Antihypertensive drug therapy : Where do we stand?].

Middeke M

Der Internist 2015; (56(3)):230-9 doi:10.1007/s00108-014-3570-2.

Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.

Dreischulte T, Morales DR, Bell S, Guthrie B

Kidney international 2015; (88(2)):396-403 doi:10.1038/ki.2015.101.

Heart failure with preserved ejection fraction: uncertainties and dilemmas.

Ferrari R, Böhm M, Cleland JG, et al.

European journal of heart failure 2015; (17(7)):665-71 doi:10.1002/ejhf.304.

[Hypertensive emergencies and urgencies].

Phan DG, Dreyfuss-Tubiana C, Blacher J

Presse medicale (Paris, France : 1983) 2015; (44(7-8)):737-44.

T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.

Hinojar R, Varma N, Child N, et al.

Circulation. Cardiovascular imaging 2015; (8(12)).

Dietary Patterns and Blood Pressure in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ndanuko RN, Tapsell LC, Charlton KE, et al.

Advances in nutrition (Bethesda, Md.) 2016; (7(1)):76-89 doi:10.3945/an.115.009753.

The association of severity of retinal vascular changes and cardiac remodelling in systemic hypertension.

Varghese M, Adhyapak SM, Thomas T, et al.

Therapeutic advances in cardiovascular disease 2016; (10(4)):224-30 doi:10.1177/1753944716630869.

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.

Catalá-López F, Macías Saint-Gerons D, González-Bermejo D, et al.

PLoS medicine 2016; (13(3)):e1001971 doi:10.1371/journal.pmed.1001971.

Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis.

Hofmann NP, Giusca S, Klingel K, et al.

Case reports in cardiology 2016; (2016()):2461502 doi:10.1155/2016/2461502.

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.

Rodrigues JC, Rohan S, Ghosh Dastidar A, et al.

European radiology 2017; (27(3)):1125-1135 doi:10.1007/s00330-016-4468-2.

Discrimination of the "Athlete's Heart" from real disease by electrocardiogram and echocardiogram.

Erickson CC

Cardiology in the young 2017; (27(S1)):S80-S88 doi:10.1017/S1047951116002286.

Hypertensive Emergency.

Suneja M, Sanders ML

The Medical clinics of North America 2017; (101(3)):465-478 doi:10.1016/j.mcna.2016.12.007.

Severe Asymptomatic Hypertension: Evaluation and Treatment.

Gauer R

American family physician 2017; (95(8)):492-500.

Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.

Wang S, Hu H, Lu M, et al.

European radiology 2017; (27(11)):4620-4630 doi:10.1007/s00330-017-4841-9.

The Transition From Hypertension to Heart Failure: Contemporary Update.

Messerli FH, Rimoldi SF, Bangalore S

JACC. Heart failure 2017; (5(8)):543-551 doi:10.1016/j.jchf.2017.04.012.

Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.

Runte KE, Bell SP, Selby DE, et al.

Circulation. Heart failure 2017; (10(8)) doi:10.1161/CIRCHEARTFAILURE.117.004311.

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial.

Ruschitzka F, Borer JS, Krum H, et al.

European heart journal 2017; (38(44)):3282-3292 doi:10.1093/eurheartj/ehx508.

Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?

Messerli FH, Bangalore S, Bavishi C, Rimoldi SF

Journal of the American College of Cardiology 2018; (71(13)):1474-1482 doi:10.1016/j.jacc.2018.01.058.

Left atrial dilatation: A target organ damage in young to middle-age hypertensive patients. The Campania Salute Network.

Mancusi C, Canciello G, Izzo R, et al.

International journal of cardiology 2018; (265()):229-233 doi:10.1016/j.ijcard.2018.03.120.

Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians.

Anand I

American journal of cardiovascular drugs : drugs, devices, and other interventions 2018; (18(5)):333-345 doi:10.1007/s40256-018-0277-0.

Should ACE inhibitors and ARBs be used in combination in children?

Stotter BR, Ferguson MA

Pediatric nephrology (Berlin, Germany) 2019; (34(9)):1521-1532 doi:10.1007/s00467-018-4046-8.

ESC Council on hypertension position document on the management of hypertensive emergencies.

van den Born BH, Lip GYH, Brguljan-Hitij J, et al.

European heart journal. Cardiovascular pharmacotherapy 2019; (5(1)):37-46 doi:10.1093/ehjcvp/pvy032.

Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.

Yano Y, Reis JP, Colangelo LA, et al.

JAMA 2018; (320(17)):1774-1782 doi:10.1001/jama.2018.13551.

Resistant Hypertension From Renal Artery Stenosis Leading to Heart Failure With Preserved Ejection Fraction.

Alyamani M, Thomas J, Shanks M, Oudit GY

Journal of investigative medicine high impact case reports 2018; (6()):2324709618816501 doi:10.1177/2324709618816501.

Hypertensive emergency presenting with acute spontaneous subdural hematoma.

Haddadin F, Munoz Estrella A, Herzog E

Journal of cardiology cases 2019; (19(1)):25-28 doi:10.1016/j.jccase.2018.09.001.

Implementing Home Blood Pressure Monitoring into Clinical Practice.

Liyanage-Don N, Fung D, Phillips E, Kronish IM

Current hypertension reports 2019; (21(2)):14 doi:10.1007/s11906-019-0916-0.

Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

Kanagala P, Cheng ASH, Singh A, et al.

JACC. Cardiovascular imaging 2019; (12(11 Pt 2)):2291-2301 doi:10.1016/j.jcmg.2018.11.031.

Secondary Hypertension in Children and Adolescents: Novel Insights.

Chrysaidou K, Chainoglou A, Karava V, et al.

Current hypertension reviews 2020; (16(1)):37-44 doi:10.2174/1573402115666190416152820.

Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Brooks JE, Soliman EZ, Upadhya B

Current hypertension reports 2019; (21(6)):47 doi:10.1007/s11906-019-0952-9.

Cutaneous effects of antihypertensive drugs.

Baccino D, Merlo G, Cozzani E, et al.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2020; (155(2)):202-211 doi:10.23736/S0392-0488.19.06360-0.

Hypertensive Emergencies: A Review of Common Presentations and Treatment Options.

Brathwaite L, Reif M

Cardiology clinics 2019; (37(3)):275-286 doi:10.1016/j.ccl.2019.04.003.

Interrelations Between Arterial Stiffness, Target Organ Damage, and Cardiovascular Disease Outcomes.

Vasan RS, Short MI, Niiranen TJ, et al.

Journal of the American Heart Association 2019; (8(14)):e012141 doi:10.1161/JAHA.119.012141.

The Evolution from Hypertension to Heart Failure.

Sorrentino MJ

Heart failure clinics 2019; (15(4)):447-453 doi:10.1016/j.hfc.2019.06.005.

Hypertension and Heart Failure.

Slivnick J, Lampert BC

Heart failure clinics 2019; (15(4)):531-541 doi:10.1016/j.hfc.2019.06.007.

Diagnosis and treatment of hypertensive emergencies and urgencies among Italian emergency and intensive care departments. Results from an Italian survey: Progetto GEAR (Gestione dell'Emergenza e urgenza in ARea critica).

Saladini F, Mancusi C, Bertacchini F, et al.

European journal of internal medicine 2020; (71()):50-56 doi:10.1016/j.ejim.2019.10.004.

Coronary microvascular dysfunction in hypertrophy and heart failure.

Camici PG, Tschöpe C, Di Carli MF, et al.

Cardiovascular research 2020; (116(4)):806-816 doi:10.1093/cvr/cvaa023.

NSAIDs in CKD: Are They Safe?

Baker M, Perazella MA

American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (76(4)):546-557 doi:10.1053/j.ajkd.2020.03.023.

Hypertensive emergencies and urgencies in emergency departments: a systematic review and meta-analysis.

Astarita A, Covella M, Vallelonga F, et al.

Journal of hypertension 2020; (38(7)):1203-1210 doi:10.1097/HJH.0000000000002372.

Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.

Niu J, Zeng M, Wang Y, et al.

BMC cardiovascular disorders 2020; (20(1)):292 doi:10.1186/s12872-020-01553-7.

Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria.

Mishima E, Funayama Y, Suzuki T, et al.

Hypertension research : official journal of the Japanese Society of Hypertension 2021; (44(1)):88-97 doi:10.1038/s41440-020-0521-2.

Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.

Pedersen LR, Kristensen AMD, Petersen SS, et al.

Journal of clinical hypertension (Greenwich, Conn.) 2020; (22(9)):1647-1658 doi:10.1111/jch.13991.

Cardiac fibrosis.

Frangogiannis NG

Cardiovascular research 2021; (117(6)):1450-1488 doi:10.1093/cvr/cvaa324.

Imaging predictors of incident heart failure: a systematic review and meta-analysis.

Georgiopoulos G, Aimo A, Barison A, et al.

Journal of cardiovascular medicine (Hagerstown, Md.) 2021; (22(5)):378-387 doi:10.2459/JCM.0000000000001133.

2020 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Home Blood Pressure Monitoring for the Management of Arterial Hypertension.

Lin HJ, Wang TD, Yu-Chih Chen M, et al.

Acta Cardiologica Sinica 2020; (36(6)):537-561 doi:10.6515/ACS.202011_36(6).20201106A.

Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations.

Andraos J, Munjy L, Kelly MS

Blood pressure 2021; (30(4)):220-229 doi:10.1080/08037051.2021.1911622.

Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.

Kaneko H, Yano Y, Itoh H, et al.

Circulation 2021; (143(23)):2244-2253 doi:10.1161/CIRCULATIONAHA.120.052624.

Left ventricular geometry transition in hypertensive patients with heart failure with preserved ejection fraction.

Guan P, Gu J, Song ZP, et al.

ESC heart failure 2021; (8(4)):2784-2790 doi:10.1002/ehf2.13349.

Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies.

Tadic M, Sala C, Carugo S, et al.

Journal of hypertension 2021; (39(10)):2103-2112 doi:10.1097/HJH.0000000000002898.

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension.

Kasiakogias A, Rosei EA, Camafort M, et al.

Journal of hypertension 2021; (39(8)):1522-1545 doi:10.1097/HJH.0000000000002910.

Posterior Reversible Encephalopathy Syndrome Associated With Coarctation of the Aorta.

Bilitardo IO, Watashi DM, Sene DR, Teixeira GS

Cureus 2021; (13(8)):e17456 doi:10.7759/cureus.17456.

Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials.

Zhao M, Qu H, Wang R, et al.

Medicine 2021; (100(35)):e26544 doi:10.1097/MD.0000000000026544.

Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry.

Fragoulis C, Dimitriadis K, Siafi E, et al.

European journal of preventive cardiology 2022; (29(1)):194-201 doi:10.1093/eurjpc/zwab159.

Hypertensive Heart Failure in Asia.

Rismiati H, Lee HY

Pulse (Basel, Switzerland) 2021; (9(3-4)):47-56 doi:10.1159/000518661.

Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community.

Vasan RS, Song RJ, Xanthakis V, et al.

Hypertension (Dallas, Tex. : 1979) 2022; (79(3)):505-515 doi:10.1161/HYPERTENSIONAHA.121.18502.

Global proliferation and clinical consequences of non-validated automated BP devices.

Whelton PK, Picone DS, Padwal R, et al.

Journal of human hypertension 2023; (37(2)):115-119 doi:10.1038/s41371-022-00667-z.

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.

Sayin BY, Oto A

Cardiology and therapy 2022; (11(2)):203-230 doi:10.1007/s40119-022-00260-y.

Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodeling.

Bewarder Y, Lauder L, Kulenthiran S, et al.

International journal of cardiology. Heart & vasculature 2022; (40()):101044 doi:10.1016/j.ijcha.2022.101044.

Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Zhou H, Peng W, Li F, et al.

Frontiers in cardiovascular medicine 2022; (9()):875327 doi:10.3389/fcvm.2022.875327.

Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?

Deschaine B, Verma S, Rayatzadeh H

Cardiac failure review 2022; (8()):e23 doi:10.15420/cfr.2022.11.

Cardiac Complications of Hypertensive Emergency: Classification, Diagnosis and Management Challenges.

Talle MA, Ngarande E, Doubell AF, Herbst PG

Journal of cardiovascular development and disease 2022; (9(8)) doi:10.3390/jcdd9080276.

Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?

Schneider CA, Pfister R

Herz 2022; (47(5)):395-400 doi:10.1007/s00059-022-05134-6.

Sex, gender, and subclinical hypertensiveorgan damage-heart.

Cuspidi C, Gherbesi E, Sala C, Tadic M

Journal of human hypertension 2023; (37(8)):626-633 doi:10.1038/s41371-022-00750-5.

From Structural to Functional Hypertension Mediated Target Organ Damage-A Long Way to Heart Failure with Preserved Ejection Fraction.

Mancusi C, Lembo M, Manzi MV, et al.

Journal of clinical medicine 2022; (11(18)) doi:10.3390/jcm11185377.

Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies.

Zhan Q, Peng W, Wang S, Gao J

Journal of cardiovascular translational research 2023; (16(2)):310-326 doi:10.1007/s12265-022-10324-y.

2022 Thai Hypertension Society guidelines on home blood pressure monitoring.

Kunanon S, Roubsanthisuk W, Chattranukulchai P, et al.

Journal of clinical hypertension (Greenwich, Conn.) 2022; (24(9)):1139-1146 doi:10.1111/jch.14569.

Standardized home blood pressure monitoring: Rationale behind the 722 protocol.

Lin HJ, Pan HY, Chen CH, et al.

Journal of clinical hypertension (Greenwich, Conn.) 2022; (24(9)):1161-1173 doi:10.1111/jch.14549.

Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA).

Van Minh H, Van Huy T, Long DPP, Tien HA

Journal of clinical hypertension (Greenwich, Conn.) 2022; (24(9)):1121-1138 doi:10.1111/jch.14580.

Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts.

Brassington K, Kanellakis P, Cao A, et al.

Frontiers in immunology 2022; (13()):1040233 doi:10.3389/fimmu.2022.1040233.

Hypertensive Heart Disease-The Imaging Perspective.

Ismail TF, Frey S, Kaufmann BA, et al.

Journal of clinical medicine 2023; (12(9)) doi:10.3390/jcm12093122.

Therapeutic roles of thiazides and loop diuretics in blood pressure control and renal protection against chronic kidney disease.

Jo W, Koh ES, Chung S

Clinical hypertension 2023; (29(1)):14 doi:10.1186/s40885-023-00238-5.

Hypertensive Heart Disease: A Narrative Review Series-Part 2: Macrostructural and Functional Abnormalities.

Nemtsova V, Burkard T, Vischer AS

Journal of clinical medicine 2023; (12(17)) doi:10.3390/jcm12175723.

Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events.

Lembo M, Pacella D, Manzi MV, et al.

European heart journal open 2023; (3(5)):oead102 doi:10.1093/ehjopen/oead102.

Clinical Profile of Patients with Hypertensive Emergency Referred to a Tertiary Hospital in the Western Cape Province of South Africa.

Talle MA, Doubell AF, Robbertse PS, et al.

Current hypertension reviews 2023; (19(3)):194-205 doi:10.2174/0115734021266958231101094556.

Management of Inpatient Elevated Blood Pressures : A Systematic Review of Clinical Practice Guidelines.

Wilson LM, Herzig SJ, Steinman MA, et al.

Annals of internal medicine 2024; (177(4)):497-506 doi:10.7326/M23-3251.

Hypertensive Emergency Team-Based Learning.

Nguyen K, Shin JG, Andrusaitis J

Journal of education & teaching in emergency medicine 2024; (9(2)):T1-T39 doi:10.21980/J8BP90.

Challenges in Echocardiography for the Diagnosis and Prognosis of Non-Ischemic Hypertensive Heart Disease.

Kadoglou NPE, Mouzarou A, Hadjigeorgiou N, et al.

Journal of clinical medicine 2024; (13(9)) doi:10.3390/jcm13092708.

Hypertension and left ventricular hypertrophy.

Đorđević DB, Koračević GP, Đorđević AD, Lović DB

Journal of hypertension 2024; (42(9)):1505-1515 doi:10.1097/HJH.0000000000003774.

The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association.

Bress AP, Anderson TS, Flack JM, et al.

Hypertension (Dallas, Tex. : 1979) 2024; (81(8)):e94-e106 doi:10.1161/HYP.0000000000000238.

Physical exercise in hypertensive heart disease: From the differential diagnosis to the complementary role of exercise.

Pastore MC, Cavigli L, Olivoni G, et al.

International journal of cardiology 2024; (410()):132232 doi:10.1016/j.ijcard.2024.132232.

A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers.

Wang Y, Ren Q, Luo H, et al.

Reviews in cardiovascular medicine 2023; (24(4)):107 doi:10.31083/j.rcm2404107.

Assessing Myocardial Strain and Myocardial Work as a Marker for Hypertensive Heart Disease: A Meta-Analysis.

Rabkin SW

Reviews in cardiovascular medicine 2023; (24(8)):217 doi:10.31083/j.rcm2408217.

Cardiovascular implications in adolescent and young adult hypertension.

Raina R, Khooblall A, Shah R, et al.

Reviews in cardiovascular medicine 2022; (23(5)):166 doi:10.31083/j.rcm2305166.

[The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects].

Borisova EV, Barsukov AV, Glebova SA, Airapetyan AV

Kardiologiia 2024; (64(7)):64-71 doi:10.18087/cardio.2024.7.n2545.

The role of diagnostic modalities in differentiating hypertensive heart disease and hypertrophic cardiomyopathy: strategies in adults for potential application in paediatrics.

Wagner MJ, Morgan C, Rodriguez Lopez S, et al.

Cardiology in the young 2025; (35(1)):1-15 doi:10.1017/S1047951124026052.

Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular Hypertrophy.

Koracevic G, Stojanovic M, Zdravkovic M, et al.

Current vascular pharmacology 2025; (23(4)):247-254 doi:10.2174/0115701611351415241212092014.

Optimizing renin-angiotensin-aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks.

Spencer S, Bhandari S

Current opinion in nephrology and hypertension 2025; (34(6)):469-476 doi:10.1097/MNH.0000000000001076.

Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.

Bensaaud A, Seery S, Gibson I, et al.

The Cochrane database of systematic reviews 2025; (5()):CD013729 doi:10.1002/14651858.CD013729.pub2.

Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure With Preserved Ejection Fraction: A Systematic Review.

Santos Guzmán MV, Rivera D, Reyna Guerrero IM, et al.

Cureus 2025; (17(5)):e84129 doi:10.7759/cureus.84129.

Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial.

Lee V, Dalakoti M, Zheng Q, et al.

Nature communications 2025; (16(1)):6981 doi:10.1038/s41467-025-62203-0.

[Diagnosis and treatment of heart failure with preserved ejection fraction].

Soltani S, Bauersachs J

Herz 2025; (50(5)):395-404 doi:10.1007/s00059-025-05327-9.

Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Khan SS, Abdalla M, Bello NA, et al.

Circulation 2025; (152(11)):e219-e238 doi:10.1161/CIR.0000000000001355.

Acute kidney injury and morbi-mortality associated with "triple whammy" combination: Systematic review and meta-analysis.

Calvo DM, Saiz LC, Leache L, et al.

British journal of clinical pharmacology 2025; (91(11)):3031-3041 doi:10.1002/bcp.70263.

Current status of the use of validated home blood pressure monitoring devices among Korean patients with hypertension.

Lee J, Kim YM, Yoo S, et al.

Hypertension research : official journal of the Japanese Society of Hypertension 2025; (48(11)):2811-2818 doi:10.1038/s41440-025-02364-z.

Digital-Based Nutrition Interventions Employing the Dietary Approaches to Stop Hypertension (DASH) Diet: A Systematic Scoping Review.

Dodge E, Kelly PJ, Aboul-Enein BH

International journal of hypertension 2025; (2025()):6175223 doi:10.1155/ijhy/6175223.

Evaluation of Left Atrial Function in Patients with Hypertensive Heart Disease and Preserved Ejection Fraction Using Real-Time, Three- Dimensional Speckle Tracking Imaging.

He X, Yang X, Guo P, Ran H

Kardiologiia 2025; (65(8)):63-70 doi:10.18087/cardio.2025.8.n2856.

Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT.

Derington CG, Berchie RO, Greene T, et al.

Journal of the American College of Cardiology 2025; (86(17)):1437-1448 doi:10.1016/j.jacc.2025.07.037.

Selecting the optimal method for assessment of hypertension-mediated organ damage: a personalized approach.

Gerdts E, Benetos A, Bruno RM, et al.

European journal of preventive cardiology 2026; (33(7)):1021-1032 doi:10.1093/eurjpc/zwag052.

Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes.

Joshi P, Rick G, Mesineni S, et al.

Cardiovascular diabetology. Endocrinology reports 2026; (12(1)):4 doi:10.1186/s40842-025-00268-y.

An expert opinion on heart failure in hypertensive heart disease.

Díez J, González A, Kirabo A, et al.

European journal of heart failure 2026; (28(2)):217-232 doi:10.1093/ejhf/xuag004.

Role of natriuretic peptides and cardiac troponins in staging hypertensive heart disease: the REMODEL study.

Sharp A, Aw TC, Le TT, et al.

European journal of heart failure 2026; doi:10.1093/ejhf/xuaf001.

Hypertensive Heart Disease and HFpEF: What We Have Learned in the Last Decade.

Ono R, Falcão LM

The American journal of cardiology 2026; (270()):113-119 doi:10.1016/j.amjcard.2026.04.006.

Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.

Neuen BL, Major RW, Grams ME, et al.

Nature medicine 2026; (32(7)):2629-2638 doi:10.1038/s41591-026-04437-z.

How difficult is the diagnosis of heart failure with preserved ejection fraction.

Cesari A, Sacco A, Oliva FG

European heart journal supplements : journal of the European Society of Cardiology 2026; (28(Suppl 5)):v82-v86 doi:10.1093/eurheartjsupp/suag040.

Echocardiographic assessment in arterial hypertension: a contemporary narrative review.

Naderi H, Victor K, Williams L, et al.

Echo research and practice 2026; (13(1)).

Hypertension and left ventricular geometry: Diagnosis, prognosis, and management.

Mutai SM, Kadambi N, Moazzam M, Oktay AA

EXCLI journal 2026; (25()):756-775 doi:10.17179/excli2026-9416.